LIONSGATE STUDIOS CORP (LION)

CA53626M1041 - Common Stock

8.09  +0.24 (+3.06%)

After market: 8.09 0 (0%)

Fundamental Rating

2

LION gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. LION scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LION is valued expensive and it does not seem to be growing.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

LION had positive earnings in the past year.

1.2 Ratios

LION's Return On Assets of 2.08% is fine compared to the rest of the industry. LION outperforms 71.21% of its industry peers.
With a decent Return On Equity value of 2.17%, LION is doing good in the industry, outperforming 74.24% of the companies in the same industry.
Industry RankSector Rank
ROA 2.08%
ROE 2.17%
ROIC N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LION does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for LION remains at a similar level compared to 1 year ago.
LION has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

LION has an Altman-Z score of 39.82. This indicates that LION is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of LION (39.82) is better than 100.00% of its industry peers.
LION has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 39.82
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

LION has a Current Ratio of 0.02. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.02, LION is not doing good in the industry: 98.48% of the companies in the same industry are doing better.
A Quick Ratio of 0.02 indicates that LION may have some problems paying its short term obligations.
LION has a Quick ratio of 0.02. This is amonst the worse of the industry: LION underperforms 98.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02

More info and screens

0

3. Growth

3.1 Past

The earnings per share for LION have decreased strongly by -27.28% in the last year.
EPS 1Y (TTM)-27.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

LION is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.34% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-51.39%
EPS Next 3Y26.16%
EPS Next 5Y-1.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 44.94, which means the current valuation is very expensive for LION.
68.18% of the companies in the same industry are more expensive than LION, based on the Price/Earnings ratio.
LION's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.41.
Industry RankSector Rank
PE 44.94
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LION's earnings are expected to grow with 26.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.39%
EPS Next 3Y26.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LION!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIONSGATE STUDIOS CORP

NASDAQ:LION (1/3/2025, 8:00:02 PM)

After market: 8.09 0 (0%)

8.09

+0.24 (+3.06%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-08 2024-11-08/amc
Earnings (Next)N/A N/A
Inst Owners9.14%
Inst Owner Change3.8%
Ins OwnersN/A
Ins Owner Change0%
Market Cap2.34B
Analysts84.44
Price Target10.54 (30.28%)
Short Float %4.72%
Short Ratio5.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 44.94
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.03
P/tB 3.03
EV/EBITDA N/A
EPS(TTM)0.18
EY2.22%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS2.67
TBVpS2.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.08%
ROE 2.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 39.82
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2Y-51.39%
EPS Next 3Y26.16%
EPS Next 5Y-1.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1401.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y156.67%
EBIT Next 5Y110.23%
FCF growth 1Y0.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.19%
OCF growth 3YN/A
OCF growth 5YN/A